Document ID: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-caed-1_15-cv-01243/USCOURTS-caed-1_15-cv-01243-0/pdf.json

Parties Involved:
Jeffrey Fairbairn
Plaintiff
Janssen Pharmaceuticals, Inc.
Defendant
Johnson & Johnson
Defendant

Document Text:

1

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

THOMAS SIMS (SBN: 264174)

tsims@baronbudd.com

BARON & BUDD, P.C.

3102 Oak Lawn Ave, Suite 1100

Dallas, Texas 75219

Telephone: (214) 521-3605

Facsimile: (214) 520-1181

Attorneys for Plaintiff

UNITED STATES DISTRICT COURT 

EASTERN DISTRICT OF CALIFORNIA

JEFFREY FAIRBAIRN;

 Plaintiff,

 v.

JOHNSON & JOHNSON; and 

JANSSEN PHARMACEUTICALS, INC.; 

Defendants.

Case No.: 1:15-cv-01243-SAB

ORDER TO CONTINUE 

STATUS CONFERENCE

Counsel for Plaintiff has notified the Court that the complaint has not been served on 

Defendants and further that a Notice of Tag Along regarding this matter and MDL No. 2642, In Re: 

Fluoroquinolone Products Liability Litigation, has been filed with the United States Judicial Panel on 

Multidistrict Litigation (“JPML”). Plaintiff’s counsel stated that a Conditional Transfer Order 

(“CTO”) will likely be entered by the JPML in the coming days.

In light of the foregoing, the Court hereby ORDERS that the Mandatory Status Conference 

currently set for November 10, 2015 at 9:30 a.m. is continued to January 4, 2016 at 9:00 a.m.

IT IS SO ORDERED.

Dated: November 6, 2015 

UNITED STATES MAGISTRATE JUDGE

Case 1:15-cv-01243---SAB Document 5 Filed 11/06/15 Page 1 of 1